Elder Granger, Director at Better Therapeutics, Inc. (BTTX), bought 1,000 shares at $6.66 ($7K) on 2021-12-03, disclosed to the SEC on 2021-12-07.
Open-market purchase of $7k BTTX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| CI | SELL | 2024-06-13 | $338K | — | Filing → |
| BTTX | BUY | 2023-07-31 | $25K | — | Filing → |
| BTTX | BUY | 2023-05-18 | $522 | — | Filing → |